| Secondary |
| Hypertension |
26.7% |
| Musculoskeletal Pain |
13.3% |
| Product Used For Unknown Indication |
13.3% |
| Diabetes Mellitus |
6.7% |
| Fungal Skin Infection |
6.7% |
| Herpes Zoster |
6.7% |
| Hypercholesterolaemia |
6.7% |
| Bronchitis |
3.3% |
| Cutaneous Amyloidosis |
3.3% |
| Dementia Alzheimer's Type |
3.3% |
| Hypoglycaemia |
3.3% |
| Iron Deficiency Anaemia |
3.3% |
| Pyrexia |
3.3% |
|
| Pyrexia |
20.0% |
| Arrhythmia |
10.0% |
| Blood Potassium Increased |
10.0% |
| Bradycardia |
10.0% |
| Electrocardiogram Qt Prolonged |
10.0% |
| Liver Disorder |
10.0% |
| Renal Failure Acute |
10.0% |
| Shock |
10.0% |
| Tubulointerstitial Nephritis |
10.0% |
|
| Concomitant |
| Hypertension |
20.9% |
| Drug Use For Unknown Indication |
13.4% |
| Rheumatoid Arthritis |
11.2% |
| Product Used For Unknown Indication |
6.7% |
| Prophylaxis |
5.2% |
| Metastatic Renal Cell Carcinoma |
4.3% |
| Osteoporosis |
4.1% |
| Colorectal Cancer |
3.8% |
| Diabetes Mellitus |
3.7% |
| Angina Pectoris |
3.2% |
| Insomnia |
3.2% |
| Hypophagia |
2.9% |
| Gastritis |
2.5% |
| Hyperlipidaemia |
2.5% |
| Type 2 Diabetes Mellitus |
2.3% |
| Cerebral Infarction |
2.2% |
| Hypercholesterolaemia |
2.1% |
| Infection Prophylaxis |
2.1% |
| Aplastic Anaemia |
1.9% |
| Parkinson's Disease |
1.9% |
|
| Renal Failure Acute |
9.7% |
| Hepatic Function Abnormal |
7.5% |
| Hiccups |
7.5% |
| Respiratory Failure |
6.5% |
| Rhabdomyolysis |
6.5% |
| Toxic Epidermal Necrolysis |
6.5% |
| Pyrexia |
5.4% |
| Tremor |
5.4% |
| Eosinophilic Pneumonia Acute |
4.3% |
| Hypoglycaemia |
4.3% |
| Lung Disorder |
4.3% |
| Renal Impairment |
4.3% |
| Tachycardia |
4.3% |
| Vomiting |
4.3% |
| Death |
3.2% |
| Herpes Zoster |
3.2% |
| Pneumocystis Jiroveci Pneumonia |
3.2% |
| Post Procedural Haemorrhage |
3.2% |
| Sensation Of Heaviness |
3.2% |
| Sepsis |
3.2% |
|
| Interacting |
| Hypertension |
50.0% |
| Nail Tinea |
25.0% |
| Prophylaxis Of Nausea And Vomiting |
25.0% |
|
| Drug Interaction |
66.7% |
| Hypotension |
33.3% |
|